Viewing nowARBI-S Tablets 10 mg (Olmesartan Medoxomil)
Olmesartan Medoxomil 10mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.

MFDS item code 201100814 · Approved 2011.02.21 · Insurance code 647803480
Treatment of essential hypertension
Essential hypertension is used to control blood pressure to normal ranges and reduce the risk of cardiovascular disease.
<Adults> The recommended initial dose is 10mg once daily, administered with or without food. If blood pressure is not adequately controlled at this dose, increase to 20mg once daily. If further blood pressure reduction is required, the dose may be increased to a maximum of 40mg daily. The blood pressure-lowering effect appears within 2 weeks after starting treatment, with the maximum effect occurring at approximately 8 weeks. If blood pressure is not controlled with this drug alone, it may be administered in combination with a thiazide diuretic such as hydrochlorothiazide. To improve adherence, it is recommended that the drug be taken at the same time each day, if possible (e.g., in the morning). For patients who may have intravascular volume depletion (e.g., patients taking diuretics, particularly those with renal impairment), it is recommended to initiate treatment at a low dose while closely monitoring their condition. <Elderly patients> No dose adjustment is necessary when administering this drug to patients aged 65 years or older. Although no overall differences in efficacy or safety have been observed between elderly and younger patients, a more sensitive response in some elderly patients cannot be ruled out. <Patients with renal impairment> The maximum dose for patients with mild to moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. <Patients with hepatic impairment> No dose adjustment is necessary for patients with mild hepatic impairment. The recommended initial dose for patients with moderate hepatic impairment is 10mg once daily, and the dose may be increased to a maximum of 20mg daily. Since there is no experience with use in patients with severe hepatic impairment, administration of this drug is not recommended.
<Children> Safety and efficacy in children have not been established.
This medication can cause serious harm or death to the fetus and newborn if taken during the second and third trimesters of pregnancy, so it should be discontinued immediately once pregnancy is confirmed. Patients allergic to any components of this medication, those who are pregnant or breastfeeding, patients undergoing renal dialysis, patients with severe liver impairment, patients with biliary obstruction, and patients with lactose intolerance should not take this medication. Caution is necessary for patients with low blood volume or sodium, as hypotension may occur upon first dose, and appropriate treatment should be received if hypotension symptoms arise. Patients with weak kidney function or those who have had a kidney transplant should regularly check kidney function and electrolyte status through blood tests and should not take this medication if they have severe kidney impairment. Special caution should be exercised when taking this medication in patients with aortic or mitral stenosis and obstructive heart disease, as blood pressure may drop sharply. This medication can cause hyperkalemia, so patients with high potassium levels should regularly monitor their blood potassium levels. Dizziness may occur, so caution is needed when driving or operating dangerous machinery. During the use of this medication, rare side effects such as chest pain, peripheral edema, dizziness, indigestion, palpitations, arthralgia, rashes, among others, may occur. If chronic diarrhea or weight loss persists, the medication should be discontinued and a physician consulted. Caution is advised if taken together with other antihypertensive drugs, potassium-sparing diuretics, or potassium supplements as it may increase serum potassium levels. Combining with non-steroidal anti-inflammatory drugs may impair kidney function, requiring careful monitoring of fluid intake and kidney function tests. During pregnancy, the drug can have serious effects on the fetus; if pregnancy is discovered, it should be discontinued immediately, and caution is advised during breastfeeding as side effects may occur in the infant. Safety in pediatrics has not been established, so it is preferable not to administer it to children. Elderly patients may have increased body drug concentration, so caution is necessary during dosage. In the case of overdose, hypotension and palpitations may occur, and if symptoms are severe, immediate medical attention is required. Although this medication has been reported to have a low risk of carcinogenicity or genotoxicity with long-term use, it is important to consult a physician if unusual symptoms occur during its use.
Dizziness
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and humidity, so it should be stored in a tightly sealed container. It is advisable to keep the storage temperature between 1 to 25 degrees Celsius at room temperature.
White round film-coated tablets
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowOlmesartan Medoxomil 10mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
JW Pharmaceutical Corporation

Olmesartan Medoxomil 40mg
Tablet · Prescription medication
JW Pharmaceutical Corp.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
JW Pharmaceutical Corporation

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Dongkuk Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
DongKook Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.